Deloitte gears up for the launch of a $20 million XPRIZE to irradicate cancer

 XPRIZE, the incentivized prize competition for breakthrough science and technology, has announced three new prizes. Among them — ALS, avatars and Deloitte’s Cancer XPRIZE. Deloitte is working in conjunction with the National Cancer Institute and Vice President Joe Biden’s Cancer Moonshot initiative to bring some of the best and brightest minds together to rid the world of what… Read More
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.